elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45251058-5F612E63-0035-4DC1-A779-E43AAB7471AD
Q45251058-5F612E63-0035-4DC1-A779-E43AAB7471AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45251058-5F612E63-0035-4DC1-A779-E43AAB7471AD
Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.
P2860
Q45251058-5F612E63-0035-4DC1-A779-E43AAB7471AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45251058-5F612E63-0035-4DC1-A779-E43AAB7471AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
44ab0deedcccc7f350b78fd8e8fcc5b30fe0fbfb
P2860
Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram